Blitz Bureau
NEW DELHI: US Senator Ben Sasse of Nebraska has gone on record stating he had been taking daraxonrasib after being diagnosed with stage 4 metastatic pancreatic cancer in December 2025. Doctors initially told Sasse that he only had three or months to live.
Sasse called daraxonrasib a “miracle drug” during a number of media interviews this spring, noting that his tumour volume has shrunk by 76 per cent since he began taking the drug.
Sasse said he was taking an oral therapy of daraxonrasib as part of a clinical trial.
Similar breakthroughs are emerging for some pancreatic cancer patients, including targeted therapies like zenocutuzumab, which has shown promise in certain cases.
